Completed
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors
NCT03343054
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan
- Kanagawa Cancer Center Yokohama, Kanagawa, Japan